CSE:MSET.W - Post by User
Post by
Betteryear2on Mar 17, 2022 4:31pm
257 Views
Post# 34523218
Issues Letter to Shareholders CSE: MSET
Issues Letter to Shareholders CSE: MSETTORONTO, March 17, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs, today issued a letter to shareholders from James Lanthier, Chief Executive Officer of Mindset. Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders